Our cell line development timelines and innovation are unprecedented.

This is our focus, which is why we do it best.

Ultimately, we help companies get drugs to patients faster and more cost-effectively.

Selexis actions to support the global response to COVID-19

Cell Line Development

Selexis SA, A JSR Life Sciences Company, is the global leader in cell line development with best-in-class modular technology and highly specialized solutions that enable the life sciences industry to rapidly discover, develop and commercialize innovative medicines and vaccines.

SUREtechnology Platform

Our global partners are utilizing Selexis gene technologies to advance more than 130 drug products in clinical development and the manufacture of seven commercial products. As part of a comprehensive drug development process, the Company’s technologies shorten development timelines and reduce manufacturing risks.

LATEST NEWS

XPRESSIONS BLOG

Cell Line Development: It’s More Complicated Than You Think

Just as it is well understood that silicon chips must be made in sophisticated factories with the appropriate engineering, materials handling and precision fabrication capabilities, so must biologic therapeutics with sophisticated factories that have the appropriate engineering, materials handling and precision fabrication capabilities. Only in this case, the factories are living cells. Therefore, choosing the right cellular factory for biologics manufacturing is just as critical for managing timelines, quality and ROI, as it is choosing the[...]

Read More

RECENT AND UPCOMING EVENTS

2020

BIO 2020, San Diego, CA | June 8 – 11, 2020
– Virtual Partnering Online

PEGS Boston, Boston MA | August 31 – September 4, 2020
– Presenting and Exhibiting

BIO-Europe, Munich | October 26 – 28, 2020
– Partnering

FULL CALENDAR AND ADDITIONAL DETAILS

FEATURED CONTENT

Selexis Corporate Overview Q1 2019

Selexis SA is the global leader in cell line development with best-in-class modular technology and highly specialized solutions that enable the life sciences industry to rapidly discover, develop and commercialize innovative medicines and vaccines.

Learn More

We are Social

With the ability to express any recombinant protein, including difficult-to-express proteins, Selexis is proud to have partnered global biopharmaceutical companies, supporting the development of innovative therapies across a range of diseases